HEIDI ROSE: Open Payments
NPI 1376625582 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 58 payments from 12 companies in 2025. Trend: 2023 $1,072 · 2024 $1,248 · 2025 $1,105
Food & beverage: $1,039Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $315 |
| GENZYME CORPORATION | 7 | $204 |
| ABBVIE INC. | 15 | $157 |
| Galderma Laboratories, L.P. | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Lilly USA, LLC | 2 | $50 |
| LEO Pharma Inc. | 2 | $47 |
| UCB, Inc. | 2 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $39 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, NEMLUVIO, Sotyktu, TALTZ, ADBRY, Bimzelx.
Industry payments across CA — which companies pay providers there.
